drugset / Trial / NCT00596297
Preoperative Bevacizumab for Vitreous Hemorrhage
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether preoperative intravitreal bevacizumab is effective in reducing intra-operative and postoperative bleeding in diabetic patients submitted to pars plana vitrectomy for vitreous hemorrhage.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.5 mg | Intravitreal |